Journal
CELL
Volume 118, Issue 6, Pages 757-766Publisher
CELL PRESS
DOI: 10.1016/j.cell.2004.08.014
Keywords
-
Categories
Funding
- NCRR NIH HHS [RR00037] Funding Source: Medline
- NHLBI NIH HHS [HL31823] Funding Source: Medline
- NIDDK NIH HHS [DK32890, DK20503, R01 DK020503] Funding Source: Medline
Ask authors/readers for more resources
FLVCR, a member of the major facilitator superfamily of transporter proteins, is the cell surface receptor for feline leukemia virus, subgroup C. Retroviral interference with FLVCR display results in a loss of erythroid progenitors (colony-forming units-erythroid, CFU-E) and severe anemia in cats. In this report, we demonstrate that human FLVCR exports cytoplasmic heme and hypothesize that human FLVCR is required on developing erythroid cells to protect them from heme toxicity. Inhibition of FLVCR in K562 cells decreases heme export, impairs their erythroid maturation and leads to apoptosis. FLVCR is upregulated on CFU-E, indicating that heme export is important in primary cells at this stage. Studies of FLVCR expression in cell lines suggest this exporter also impacts heme trafficking in intestine and liver. To our knowledge, this is the first description of a mammalian heme transporter.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available